D-ARTEPP Dispersible 20/160mg: Effective Malaria Treatment for Children

D-ARTEPP Dispersible 20/160mg is a high-quality Artemisinin-based Combination Therapy (ACT) specifically designed for infants and young children. It combines Dihydroartemisinin and Piperaquine Phosphate to provide fast relief from malaria symptoms and long-lasting protection against reinfection.

As a dispersible tablet, D-ARTEPP is easy to administer to babies and kids who cannot swallow pills. Simply dissolve the tablet in a small amount of water for a quick, "sharp relief" from malaria fever and parasites.

How D-ARTEPP Works

• Dihydroartemisinin (20mg): Acts rapidly to kill malaria parasites in the blood, bringing down fever quickly.
• Piperaquine Phosphate (160mg): Stays in the body longer to ensure all remaining parasites are cleared and provides short-term protection (prophylaxis) after the treatment.

Dosage and Administration

For the best results and to avoid side effects, follow these guidelines:

• Empty Stomach: Give D-ARTEPP at least 3 hours before or 3 hours after food or milk. This is crucial for safety and proper absorption.
• 3-Day Course: The treatment must be completed over 3 consecutive days. Even if the child feels better after the first day, finish the pack to prevent the malaria from coming back.
• Do Not Split: Although the tablet has a score line, it is meant to help the tablet dissolve or be swallowed, not to divide the dose into half-tablets.

Safety Information

• Target Weight: This strength is generally suitable for children weighing between 5kg and 24kg, depending on the number of tablets prescribed per day.
• NAFDAC Approved: D-ARTEPP is registered in Nigeria (NAFDAC Reg. No. B4-6979) and manufactured by Guilin Pharmaceutical, a world leader in antimalarial medicine.

Consult with a GoMed pharmacist if you are unsure about the correct dosage for your child's weight.